What is Tovaxin?

Category: Others

true

Generic name: Imilecleucel-T

Tovaxin is an experimental treatment which uses patients' own immune cells (T-Cells) as a vaccine. Cells which attack the myelin sheath in MS are isolated, irradiated to prevent replication, and then reinjected to cause the healthy parts of the immune system to defend the myelin sheaths from attack.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
0
Mild
0
None
2

Commonly reported side effects and conditions associated with Tovaxin

Side effect Patients

Why patients stopped taking Tovaxin

Multiple reasons could be selected

Reason Patients
Course of treatment ended 3
Other 1
See all 3 patients who've stopped taking Tovaxin

Duration

Stopped taking Tovaxin

Duration Patients
6 months - 1 year 1
1 - 2 years 2
Adherence
Adherence Evaluations
Always 2
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 2
Not specified 0
Last updated:

1 patient evaluation for Tovaxin

Oct 14, 2008 (Started Jun 29, 2007)

  • Effectiveness
    Can't tell (for multiple sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Cost: < $25 monthly

Jun 20, 2008 (Started Jun 29, 2007)

  • Effectiveness
    Major (for multiple sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: As needed
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Tovaxin